(Q42523780)

1 November 2017

title

Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum (English)

1 reference

1 November 2017

main subject

glyceryl 2-arachidonate

0 references

0 references

0 references

1 reference

2

1 reference

1 November 2017

12

1 reference

1 November 2017

Valeria Gasperi

7

0 references

Alessandra Musella

object named as

Alessandra Musella

6

0 references

Benjamin Cravatt

11

object named as

Benjamin F Cravatt

1 reference

1 November 2017

9

Giorgio Bernardi

1 reference

1 November 2017

Mauro Maccarrone

1

1 reference

1 November 2017

Monica Bari

3

1 reference

1 November 2017

Valentina De Chiara

4

1 reference

1 November 2017

Filomena Fezza

5

1 reference

1 November 2017

Chiara Prosperetti

8

1 reference

1 November 2017

Alessandro Finazzi-Agrò

10

1 reference

1 November 2017

language of work or name

English

0 references

publication date

20 January 2008

1 reference

1 November 2017

1 reference

1 November 2017

volume

11

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

152-159

1 reference

Role of endogenous cannabinoids in synaptic signaling

1 November 2017

cites work

1 reference

Development of the first potent and specific inhibitors of endocannabinoid biosynthesis

21 January 2018

1 reference

The molecular logic of endocannabinoid signalling

21 January 2018

1 reference

7 January 2021

Endocannabinoid-mediated synaptic plasticity in the CNS.

1 reference

7 January 2021

Neurobiology. How cannabinoids work in the brain

1 reference

7 January 2021

Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells

1 reference

7 January 2021

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses

1 reference

7 January 2021

Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors

1 reference

7 January 2021

Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons.

1 reference

7 January 2021

Postsynaptic endocannabinoid release is critical to long-term depression in the striatum

1 reference

7 January 2021

Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum.

1 reference

7 January 2021

Synapse-specific plasticity and compartmentalized signaling in cerebellar stellate cells

1 reference

7 January 2021

Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation

1 reference

7 January 2021

Endocannabinoids contribute to short-term but not long-term mGluR-induced depression in the hippocampus.

1 reference

7 January 2021

Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse

1 reference

7 January 2021

Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum.

1 reference

7 January 2021

Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice

1 reference

7 January 2021

Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells

1 reference

7 January 2021

Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

1 reference

7 January 2021

Brain monoglyceride lipase participating in endocannabinoid inactivation

1 reference

7 January 2021

2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook

1 reference

7 January 2021

Molecular characterization of a phospholipase D generating anandamide and its congeners

1 reference

7 January 2021

Anandamide transport: a critical review.

1 reference

7 January 2021

New insights into endocannabinoid degradation and its therapeutic potential

1 reference

7 January 2021

Structure and function of fatty acid amide hydrolase

1 reference

7 January 2021

Modulation of anxiety through blockade of anandamide hydrolysis

1 reference

7 January 2021

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

1 reference

7 January 2021

Biochemistry and pharmacology of endovanilloids

1 reference

7 January 2021

Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain

1 reference

7 January 2021

Multiple actions of anandamide on neonatal rat cultured sensory neurones

1 reference

7 January 2021

The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress.

1 reference

7 January 2021

Analgesic Effects of Fatty Acid Amide Hydrolase Inhibition in a Rat Model of Neuropathic Pain

1 reference

7 January 2021

Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid typ

1 reference

7 January 2021

Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels

1 reference

7 January 2021

Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus

1 reference

7 January 2021

Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus

1 reference

7 January 2021

Protective activation of the endocannabinoid system during ischemia in dopamine neurons

1 reference

7 January 2021

Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol.

1 reference

7 January 2021

Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain.

1 reference

7 January 2021

Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance

1 reference

7 January 2021

Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function

1 reference

7 January 2021

Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease

1 reference

7 January 2021

N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation

1 reference

7 January 2021

Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors.

1 reference

7 January 2021

Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.

1 reference

7 January 2021

Functional coexpression of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons.

1 reference

7 January 2021

Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity.

1 reference

7 January 2021

Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock

1 reference

7 January 2021

Identifiers

DOI

10.1038/NN2042

1 reference

Dimensions Publication ID

1 November 2017

1021736251

0 references

1 reference